doi: 10.1038/d41573-020-00151-8.
Evolution of the COVID-19 vaccine development landscape
- PMID:32887942
- DOI: 10.1038/d41573-020-00151-8
Item in Clipboard
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al. Nat Rev Drug Discov.2020 Oct.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Frontiers in the COVID-19 vaccines development.Haq EU, Yu J, Guo J.Haq EU, et al.Exp Hematol Oncol. 2020 Sep 3;9:24. doi: 10.1186/s40164-020-00180-4. eCollection 2020.Exp Hematol Oncol. 2020.PMID:32901214Free PMC article.
- What opportunities could the COVID-19 outbreak offer for sustainability transitions research on electricity and mobility?Kanda W, Kivimaa P.Kanda W, et al.Energy Res Soc Sci. 2020 Oct;68:101666. doi: 10.1016/j.erss.2020.101666. Epub 2020 Jun 29.Energy Res Soc Sci. 2020.PMID:32839695Free PMC article.Review.
- Evolution of Landscape Ecological Risk at the Optimal Scale: A Case Study of the Open Coastal Wetlands in Jiangsu, China.Liu Y, Liu Y, Li J, Lu W, Wei X, Sun C.Liu Y, et al.Int J Environ Res Public Health. 2018 Aug 8;15(8):1691. doi: 10.3390/ijerph15081691.Int J Environ Res Public Health. 2018.PMID:30096816Free PMC article.
- Evolution in the light of fitness landscape theory.Fragata I, Blanckaert A, Dias Louro MA, Liberles DA, Bank C.Fragata I, et al.Trends Ecol Evol. 2019 Jan;34(1):69-82. doi: 10.1016/j.tree.2018.10.009. Epub 2018 Dec 21.Trends Ecol Evol. 2019.PMID:30583805Review.
- An edible vaccine development for coronavirus disease 2019: the concept.Sohrab SS.Sohrab SS.Clin Exp Vaccine Res. 2020 Jul;9(2):164-168. doi: 10.7774/cevr.2020.9.2.164. Epub 2020 Jul 31.Clin Exp Vaccine Res. 2020.PMID:32864373Free PMC article.Review.
Cited by
- Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials.Calzetta L, Ritondo BL, Coppola A, Matera MG, Di Daniele N, Rogliani P.Calzetta L, et al.Vaccines (Basel). 2021 Apr 1;9(4):341. doi: 10.3390/vaccines9040341.Vaccines (Basel). 2021.PMID:33916222Free PMC article.
- The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J.Rzymski P, et al.Vaccines (Basel). 2021 Apr 14;9(4):382. doi: 10.3390/vaccines9040382.Vaccines (Basel). 2021.PMID:33919672Free PMC article.
- Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study.Lin SN, Rui J, Chen QP, Zhao B, Yu SS, Li ZY, Zhao ZY, Wang Y, Zhu YZ, Xu JW, Yang M, Liu XC, Yang TL, Luo L, Deng B, Huang JF, Liu C, Li PH, Liu WK, Xie F, Chen Y, Su YH, Zhao BH, Chiang YC, Chen TM.Lin SN, et al.Infect Dis Poverty. 2021 Apr 19;10(1):53. doi: 10.1186/s40249-021-00835-2.Infect Dis Poverty. 2021.PMID:33874998Free PMC article.
- Biolayer Interferometry Analysis for a Higher Throughput Quantification of In-Process Samples of a Rotavirus Vaccine.Carvalho SB, Dias MM, Matheise JP, Knott I, Gomes-Alves P, Alves PM.Carvalho SB, et al.Vaccines (Basel). 2022 Sep 21;10(10):1585. doi: 10.3390/vaccines10101585.Vaccines (Basel). 2022.PMID:36298449Free PMC article.
- SARS-CoV-2 variants and vulnerability at the global level.Chavda VP, Patel AB, Vaghasiya DD.Chavda VP, et al.J Med Virol. 2022 Jul;94(7):2986-3005. doi: 10.1002/jmv.27717. Epub 2022 Apr 5.J Med Virol. 2022.PMID:35277864Free PMC article.Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources